> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Senate Committee OKs $80 mil. FDA Spending Boost
- URL: https://www.fdaweb.com/senate-committee-oks-80-mil-fda-spending-boost/
- Published: 2019-09-20T12:00:00.000Z
- Updated: 2026-09-15T01:51:18.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145056

The Senate Appropriations Committee has approved an FY 2020 FDA appropriations bill (view details [here](https://strengthenfda.us11.list-manage.com/track/click?u=564aaf3ba56647cf536ecb9b0&id=281194c662&e=122703d8fb&ref=fdaweb.com) and [here](https://strengthenfda.us11.list-manage.com/track/click?u=564aaf3ba56647cf536ecb9b0&id=91c10e6ad5&e=122703d8fb&ref=fdaweb.com)), which includes $3.148 billion in discretionary funding for the agency — $80 million above the FY 2019 enacted level. The measure includes a $7 million increase for medical countermeasures initiatives, $10 million to reduce pathogens in the blood supply, $6 million for compounding prescription drugs, $7 million for advancing food safety, $8 million for responding to food outbreaks, and $2 million for Cannabidiol activities, according to the [Alliance for a Stronger FDA](https://strengthenfda.org/news/?ref=fdaweb.com). Additionally, the bill includes $15 million to address infrastructure needs at FDA buildings and laboratories. The House-reported [numbers](https://strengthenfda.us11.list-manage.com/track/click?u=564aaf3ba56647cf536ecb9b0&id=c77e17bbd0&e=122703d8fb&ref=fdaweb.com) are $3.26 billion in discretionary funding in the bill, which is $184 million above the FY 2019 enacted level, the group says.

Meanwhile, the Alliance notes that the House 9/19 passed a FY 2020 continuing resolution, which is intended to act as a vehicle to prevent a government shutdown. The measure would fund the federal government from 10/ 1 until 11/21 in order to complete the appropriations process.